Invesco Ltd. - AIMMUNE THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 102 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.15 and the average weighting 0.9%.

Links
Filings
External links
Quarter-by-quarter ownership
Invesco Ltd. ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$356,000
+104.6%
10,344
-1.0%
0.00%–
Q2 2020$174,000
+6.7%
10,446
-7.5%
0.00%–
Q1 2020$163,000
-92.6%
11,299
-83.6%
0.00%
-100.0%
Q1 2018$2,188,000
+89.4%
68,753
+22.3%
0.00%–
Q2 2017$1,155,000–56,197–0.00%–
 Download
Other shareholders

There were no reported owners of AIMMUNE THERAPEUTICS INC in Q3 2017.

NameSharesValueWeighting ↓
View complete list of AIMMUNE THERAPEUTICS INC shareholders